- Home
- PCVX vs CROX Comparison
PCVX vs CROX Comparison
Compare PCVX & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | CROX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.6B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PCVX | CROX |
|---|---|---|
| Price | $62.62 | $122.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 12 |
| Target Price | $88.25 | ★ $99.90 |
| AVG Volume (30 Days) | 908.4K | ★ 1.0M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.83 |
| Revenue | N/A | ★ $4,040,647,000.00 |
| Revenue This Year | N/A | $2.01 |
| Revenue Next Year | N/A | $2.60 |
| P/E Ratio | ★ N/A | $18.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.87 | $73.21 |
| 52 Week High | $65.00 | $141.28 |
Technical Indicators
Market Signals| Indicator | PCVX | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 39.34 |
| Support Level | $52.18 | $116.74 |
| Resistance Level | $65.00 | $128.89 |
| Average True Range (ATR) | 2.20 | 4.43 |
| MACD | 0.50 | -1.67 |
| Stochastic Oscillator | 90.12 | 5.37 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.